Long COVID clinical evaluation, research and impact on society: a global expert consensus

Andrew G. Ewing, David Joffe, Svetlana Blitshteyn, et. al. Annals of Clinical Microbiology and Antimicrobials volume 24, Article number: 27 (2025)  Abstract Background Long COVID is a complex, heterogeneous syndrome affecting over four hundred million people globally. There…[...]

Read More

🧠 Long COVID and Sleep Disorders: Mechanisms, Brain Centers, and Therapeutic Advances (2025 Review)

Sleep disturbances have emerged as one of the most persistent and disruptive symptoms of Long COVID, affecting up to 40–76% of patients months after infection2. This article synthesizes 2025 peer-reviewed…[...]

Read More

🫁 Long COVID and Gas Exchange Dysfunction: Interstitial Fibrosis, Therapeutic Strategies, and Reversibility

Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), continues to affect millions globally, with shortness of breath and impaired gas exchange among its most persistent symptoms. Recent peer-reviewed studies…[...]

Read More

Johnson & Johnson Lead Scientist Confesses J&J Covid Vaccine Was ‘Not Safe and Effective’ – “Lack of Research”

by Cristina Laila The O’Keefe Media Group on Tuesday released undercover video of a lead scientist at pharmaceutical giant Johnson & Johnson admitting the Covid vaccine was not safe and effective.…[...]

Read More

Short-Term Outcomes in Patients With Coexistence of COVID-19 Infection and Vitamin D Deficiency: A Large Cohort Study

Yi-Ju Chan • Chia-Chen Chen • Jheng-Yan Wu, Short-Term Outcomes in Patients With Coexistence of COVID-19 Infection and Vitamin D Deficiency: A Large Cohort Study. Cureus 16(10): e71952. doi:10.7759/cureus.71952 Abstract Introduction: Vitamin D deficiency…[...]

Read More

Moderna’s COVID-19 Vaccine Spikevax Receives Full FDA Approval for Children Aged 6 Months to 11 Years at “Increased Risk”

by Jim Hᴏft, TGP The U.S. Food and Drug Administration (FDA) has officially granted full approval to Moderna’s controversial mRNA COVID-19 vaccine, Spikevax, for children as young as 6 months old…[...]

Read More